Preventive Antibiotic Serum Levels During Caesarean Section
NCT ID: NCT02838940
Last Updated: 2016-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
250 participants
INTERVENTIONAL
2016-08-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Preventive antibiotic treatment before performing invasive procedures is a basic element in preventing infections. The essence of preventive antibiotic treatment is strengthening the defense mechanisms of the immune system by preserving a certain drug levels in the blood. The timing of giving the antibiotics is very important. Several research groups have tried to check the levels of Cefazolin (the most common antibiotics in the field of obstetrics) in serum and adipose tissue in women during cesarean. These groups presented conflicting research results.
OBJECTIVE
This study will discuss the preventive antibiotic treatment levels accepted prior cesareans, to determine:
1. What are the factors affecting the level of drug in the blood?
2. Is there a fixed time which beyond it, blood drug levels are below the MIC(Minimal Inhibitory Concentration)?
3. Is the provision of usual preventive care also addresses the situations of metabolic disorder?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Prophylactic Antibiotics for Cesarean Sections
NCT00330278
Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures
NCT06255652
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
NCT00133029
Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery.
NCT01880112
Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome
NCT06030713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preventive antibiotic treatment before performing invasive procedures is a basic element in preventing infections. The essence of preventive antibiotic treatment is strengthening the defense mechanisms of the immune system by preserving a certain drug levels in the blood. The timing of giving the antibiotics is very important. Several research groups have tried to check the levels of Cefazolin (the most common antibiotics in the field of obstetrics) in serum and adipose tissue in women during cesarean. These groups presented conflicting research results.
OBJECTIVE
This study will discuss the preventive antibiotic treatment levels accepted prior cesareans, to determine:
1. What are the factors affecting the level of drug in the blood?
2. Is there a fixed time which beyond it, blood drug levels are below the MIC(Minimal Inhibitory Concentration)?
3. Is the provision of usual preventive care also addresses the situations of metabolic disorder?
PATIENTS \& METHODS
Women that meet the inclusion criteria and are about to undergo cesarean in different indications, in elective and urgent way.
1. Before performing TIMEOUT outside the surgery room, The investigators will explanation about the process and purpose of the study, and informed consent will be obtained.
2. Prior to the anesthesia by an anesthesiologist, the women will receive one dose of 1 g Cefazolin the usual loading dose. Women with a BMI over 30 will receive Cefazolin of about 2 grams.
3. With the beginning of the first incision in the skin, first blood sample will be taken to test levels of antibiotics in serum.
4. Second blood sample to test drug levels in serum will be taken while closing the surgical incision in the skin at the end of the operation.
5. The continuation of post surgery recovery process will be as usual, in accordance with departmental protocols.
With the results of tissue and serum samples, segmentation which compares the drug levels in the different tissues will be performed.Also, the correlation between drug levels in women with different BMI and morbidities that may cause measurable or not pharmacokinetic changes will be examined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cesarean in different indications
Women that are about to undergo an elective cesarean in different indications.
Blood samples.
At the beginning of the first incision in the skin, first blood sample will be taken for levels of antibiotics in serum test.
Second blood sample for drug levels in serum test, will be taken while closing the surgical incision in the skin at the end of the operation.
Cefazolin
According to the ward protocol prior to the anesthesia by an anesthesiologist, the women will receive one dose of 1 g Cefazolin the usual loading dose. Women with a BMI over 30 will receive Cefazolin of about 2 grams.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples.
At the beginning of the first incision in the skin, first blood sample will be taken for levels of antibiotics in serum test.
Second blood sample for drug levels in serum test, will be taken while closing the surgical incision in the skin at the end of the operation.
Cefazolin
According to the ward protocol prior to the anesthesia by an anesthesiologist, the women will receive one dose of 1 g Cefazolin the usual loading dose. Women with a BMI over 30 will receive Cefazolin of about 2 grams.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women who arrive to elective cesareans.
3. Age of women: 18-50 years old.
Exclusion Criteria
2. urgent surgery
3. Sensitivity to penicillin or cephalosporins antibiotics that requires antibiotics change.
4. Women who received the week before surgery antibiotic treatment
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yariv Yogev, professor
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0147-16-TLV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.